Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/2003
10/09/2003WO2003082370A2 Transcellular drug delivery system
10/09/2003WO2003082322A1 A method of modulating cellular activity
10/09/2003WO2003082312A1 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
10/09/2003WO2003082310A1 Composition and method for the treatment or prevention of il-1 mediated disorders
10/09/2003WO2003082302A2 Bioadhesive directed somatic cell therapy
10/09/2003WO2003082300A1 Use of carbon-2-modified-vitamin d analogs to induce the formation of new bone
10/09/2003WO2003082297A1 Meloxicam suppositories containing e.g. polyethylenglycol
10/09/2003WO2003082284A1 Use of desoxynojirimycin and the derivatives thereof for the treatment and prophlaxis of degenerative skin infections
10/09/2003WO2003082280A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2003082279A1 Solid preparation containing single crystal form
10/09/2003WO2003082277A1 Thiazol-2-yl-imine compounds as pde-7 inhibitors
10/09/2003WO2003082274A1 Angiogenesis inhibitors
10/09/2003WO2003082271A2 Indole derivatives having anti-angiogenetic activity
10/09/2003WO2003082269A1 Use of statins and other immunomodulatory agents in the treatment of autoimmune disease
10/09/2003WO2003082197A2 Immunosuppressant compounds, methods and uses related thereto
10/09/2003WO2003054208A3 Method of modulating release of saccharides and uses thereof
10/09/2003WO2003035048A3 Methods for the treatment of osteoarthritis and compositions thereof
10/09/2003WO2003016528A3 Oligonucleotide compositions and their use to induce apoptosis
10/09/2003WO2003016341A3 Regulation of iron uptake
10/09/2003WO2003007889A3 Therapeutic agents comprising pro-apoptotic proteins
10/09/2003WO2002094842A3 Control of myogenesis by modulation of p38 map kinase activity
10/09/2003WO2002092004A3 Use of hmg fragment as anti-inflammatory agents
10/09/2003WO2002083627A3 Ligands des integrins avss6
10/09/2003WO2002078682A3 Estrogen replacement therapy
10/09/2003WO2002077017A3 Medical uses of intercellular communication facilitating compounds
10/09/2003WO2002069905A3 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
10/09/2003WO2002055063A3 Fumaric acid amides
10/09/2003WO2002043759A3 Method and composition for modulating bone growth
10/09/2003WO2002038797A3 Modulators of bruton's tyrosine kinase, their identification and use
10/09/2003WO2002033099A3 Human kinases
10/09/2003WO2002026245A3 Use of serp-1 in combination with an immunosuppressant for influencing inflammatory and immune reactions
10/09/2003WO2002016434A9 T CELL RECEPTOR Vβ-Dβ-Jβ SEQUENCE AND METHODS FOR ITS DETECTION
10/09/2003US20030191332 Prevention of neutrophil recruitment
10/09/2003US20030191308 Quinazoline compounds
10/09/2003US20030191291 Synthetic erythropoiesis stimulating proteins
10/09/2003US20030191285 Novel g protein-coupled receptor proteins and dnas thereof
10/09/2003US20030191193 Bone disorders
10/09/2003US20030191180 Pharmaceutical compositions
10/09/2003US20030191178 Therapy for vision defects; hypotensive agents; respiratory system disorders
10/09/2003US20030191175 Indole sPLA2 inhibitors
10/09/2003US20030191167 Autoimmune disease, antiarthritic agents, antiallergens, anticancer agents
10/09/2003US20030191163 Substituted cyclic amine metalloprotease inhibitors
10/09/2003US20030191155 Triazole derivatives
10/09/2003US20030191117 Acyclic piperazine and piperidine derivatives
10/09/2003US20030191103 Hormone replacement therapy
10/09/2003US20030191098 Synergistic mixture of thalidomide antiinflammatory agnets
10/09/2003US20030191097 Hormone replacement therapy
10/09/2003US20030191094 Osteoporosis; dihydroxyvitamin D3; suppress gene expression of transcription factors
10/09/2003US20030191092 MMP inhibitors
10/09/2003US20030191079 Methods for treating and preventing infectious disease
10/09/2003US20030191074 Antibody therapy; immobilization
10/09/2003US20030191065 Insulin-like growth factor; genetic engineering; central nervous system disorders
10/09/2003US20030191057 Cardiovascular disorders; antiinflammatory agents
10/09/2003US20030190733 Desaturase genes and uses thereof
10/09/2003US20030190708 Novel hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use
10/09/2003US20030190642 Thymus expressed human cytochrome p450(p450tec)
10/09/2003US20030190613 Polynucleotide encoding an activated human T-lymphocyte-derived protein related to ubiquitin conjugating enzyme
10/09/2003US20030190375 Therapeutical use of sophora flavescens or sophora subprostrata extracts
10/09/2003US20030190360 Chronotherapeutic pharmaceutical formulation comprising core containing active agent and delayed release compression coating comprising a natural or synthetic gum applied onto surface of core
10/09/2003US20030190303 For treating allergic disorders characterized by a local immune response including inflammatory skin reactions, asthma, and arthritis
10/09/2003CA2481315A1 Lactoferrin
10/09/2003CA2480888A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003CA2480857A1 Improvements in pharmaceutical compositions
10/09/2003CA2480679A1 (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors
10/09/2003CA2480661A1 A method of modulating cellular activity
10/09/2003CA2480656A1 Bioadhesive directed somatic cell therapy
10/09/2003CA2480634A1 Use of statins and other immunomodulatory agents in the treatment of autoimmune disease
10/09/2003CA2480568A1 Thiazol-2-yl-imine compounds as pde-7 inhibitors
10/09/2003CA2480317A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
10/09/2003CA2480138A1 Transcellular drug delivery system
10/09/2003CA2479939A1 Immunosuppressant compounds, methods and uses related thereto
10/09/2003CA2479914A1 Meloxicam suppositories containing e.g. polyethylenglycol
10/09/2003CA2479205A1 Azaindoles as inhibitors of c-jun n-terminal kinases
10/09/2003CA2478918A1 Angiogenesis inhibitors
10/09/2003CA2477764A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/08/2003EP1350525A2 Matrix-free osteogenic devices, implants and methods thereof
10/08/2003EP1349944A2 Latency associated peptide for providing latency to pharmaceutically active proteins
10/08/2003EP1349930A2 Human proteins, polynucleotides encoding them and methods of using the same
10/08/2003EP1349873A2 Modulation of il-2- and il-15-mediated t cell responses
10/08/2003EP1349852A2 4-(hetero)aryl substituted indolinones
10/08/2003EP1349851A1 Compounds
10/08/2003EP1349842A1 1-dimercaptoalkylquinazolin-2,4(1h,3h)-diones as matrix metalloproteinase (mmp) inhibitors
10/08/2003EP1349841A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
10/08/2003EP1349840A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
10/08/2003EP1349836A2 Tetracyclic derivatives as spla2 inhibitors
10/08/2003EP1349834A2 Cycloalkyfused [g]-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases
10/08/2003EP1349832A2 Substituted benzoindoles as spla2 inhibitors
10/08/2003EP1349562A2 Inhibiting gs-fdh to modulate no bioactivity
10/08/2003EP1349559A1 Compositions for inducing secretion of insulin-like growth factor-1
10/08/2003EP1349558A1 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
10/08/2003EP1349557A2 Fractions of snake blood, their preparation and use as therapeutic agents
10/08/2003EP1349554A2 Compositions and methods for treating an arthritic condition
10/08/2003EP1349553A1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
10/08/2003EP1349550A1 Substituted-4-quinolones
10/08/2003EP1272230B1 Injectable bone mineral substitute material comprising bone cement and oil
10/08/2003EP1214318B1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives
10/08/2003EP1181285B1 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
10/08/2003EP1144421B1 Phosphinic pseudopeptides inhibitors of matrix metalloproteases
10/08/2003EP0994884B1 Diphosphonic acid salts for the treatment of osteoporosis
10/08/2003EP0946512B1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
1 ... 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 ... 820